Aeglea BioTherapeutics, Inc.·4

Feb 19, 5:09 PM ET

Weber Steven 4

4 · Aeglea BioTherapeutics, Inc. · Filed Feb 19, 2021

Insider Transaction Report

Form 4
Period: 2021-02-17
Weber Steven
VP, Controller&Princ Acctg Off
Transactions
  • Award

    Employee Stock Option (right to buy)

    2021-02-17+50,00050,000 total
    Exercise: $7.35Exp: 2031-02-16Common Stock (50,000 underlying)
Footnotes (1)
  • [F1]The stock option vests and becomes exercisable in 48 equal monthly installments beginning on March 17, 2021, until such time as the option is 100% vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION